Objective: To determine correlation between early protein administration and serum blood urea nitrogen (BUN) or bicarbonate (HCO 3 À ) in extremely low birth weight (ELBW) infants during the first week of life. 
Introduction
Attempts to provide premature neonates with nutrition that allows for approximation of in utero growth rates have proven largely unsuccessful, particularly in the extremely low birth weight (ELBW; <1000 g) infant.
1,2 As such, there is continued interest in defining the means to provide optimal nutrition to these infants while minimizing metabolic disturbances. Fetal energy for growth and development is principally provided by amino acids and glucose, with a small contribution from lipids. In contrast, the source of much of the nutrition provided soon after birth to ELBW infants is from glucose and lipids, with a relatively minor contribution from amino acids. While caloric deprivation is an important factor in the development of extrauterine growth restriction, insufficient protein administration is thought to have an important role as it leads to a negative nitrogen balance in the early period from which recovery is difficult. 3, 4 The protein requirements for fetal growth are between 3.5 and 4 g/kg/day, 5 while most ELBW infants receive <2 g/kg/day of protein in the immediate postnatal period. 1, 2, 6, 7 Increasing amino-acid administration in preterm infants has been shown to improve nitrogen retention and prevent the loss of lean protein mass, as well as to increase the concentration of many amino acids. 4, 8 Concerns associated with high amino-acid administration to ELBW infants in the early postnatal period include elevated blood urea nitrogen (BUN) values and metabolic acidosis. Current neonatal amino-acid preparations are crystalline formulations which, compared with older preparations of casein hydrolysates, have reduced the incidence and severity of adverse effects. 9 Several studies have demonstrated safety and tolerance of early protein administration with these new amino-acid formulations (reviewed in 10 ). Early protein administration at rates of 1 to 2 g/kg/day has also been associated with improved growth and/or neurodevelopmental outcomes compared with infants who received no protein in the first days to week of life. 4,11 -15 Since 2006 total parenteral nutrition (TPN) practice at our institution for patients <1250 g provides a stock solution of 'Early TPN' which provides 2% neonatal amino acids and 10% dextrose on day of life 0. A 2% concentration of amino acids was chosen because it provides a starting point for amino-acid administration ranging from 1 to 2 mg/kg/day, depending on the total fluid administration and the presence of additional infusions that may be necessary in the care of the infant. The amino acids are incrementally increased by 0.5 g/kg/day to reach a goal of 4 g/kg/ day. This supplies at best a mean protein intake of B2.5 g/kg/day to the neonate in the first week of life. However, this is still far below fetal protein accretion rates of 3.5 to 4 g/kg/day. Consequently, the protein and energy requirements of the ELBW are not met with current nutritional practices. Concern that increased protein administration may result in acidosis and elevated BUN has limited efforts to alter the Early TPN formulation.
The objective of this study is to determine the correlation between the amount of protein intake in the first week of life and BUN and bicarbonate (HCO 3 À ). Our hypothesis is that in ELBW infants who received early protein administration, there is no correlation between protein administration in the first week of life and BUN or HCO 3 À .
Methods
The study design was a retrospective chart review of 154 ELBWs Maternal and patient characteristics were collected. The presence or absence of common neonatal morbidities using standard Neonatal Research Network definitions were also collected and were similar to rates reported in the literature (Table 1) . Bronchopulmonary dysplasia was defined as the requirement of oxygen at 36 weeks post-conceptional age. Patent ductus arteriosis that required medical treatment with indomethacin or surgical ligation was documented. Infection with a positive blood culture for which the infant received antibiotic or anti-fungal therapy was noted as blood culture positive sepsis. The presence of modified Bell's stage II or III necrotizing enterocolitis was recorded. The highest grade of intraventricular hemorrhage from all sonograms on a specific infant was reported. Cystic periventricular leukomalacia was defined as the presence of cysts or echolucencies in the white matter around the ventricle as visualized by ultrasound. Laboratory data from postnatal days 1 to 10 and nutritional data from days 1, 4 and 7 were collected. Laboratory tests were ordered at the discretion of the clinical care team.
These neonates received parenteral nutrition exclusively for the first 3 days, which was initiated within the first 2 h after birth. Thereafter, trophic feeds were initiated and increased incrementally at the discretion of the clinical care team as the infant demonstrated feeding tolerance. A stock solution of Early TPN was used as the first intravenous fluids in all patients. Early TPN was a 10% dextrose solution containing 2 g/100 ml of amino acids and provided between 1 and 2 g/kg/day of amino acids to the neonate, dependent upon the volume of solution administered before the stock solution is replaced with another TPN solution. Subsequent TPN composition included glucose, amino acids (premasol and L-cysteine), electrolytes, vitamins, minerals and lipids. Glucose infusion rate was initiated at 4 to 6 mg/kg/min and advanced by 1 mg/kg/min per day to reach a goal of 12.5 to 14 mg/kg/min by day of life 10. Intralipid was initiated on day of life 1 at 1 g/kg/day and advanced by 0.5 g/kg/day to reach a goal of 3 g/kg/day by day of life 5 to 7. The TPN solution was incrementally advanced in amino acids by 0.5 g/kg/day to achieve a goal of 4 g/kg/day by day of life 5 to 7. TPN composition was adjusted daily on the basis of serum electrolytes and the patient's clinical status. Infants were maintained in a humidified isolette for the first days of life and typically received 80 to 100 ml/kg/day of total fluids on the first day of life. Total fluids were subsequently adjusted at the discretion of the medical team. Typical total fluid and macronutrient intake are shown in Table 2 .
Ethics
This retrospective analysis was reviewed and approved by the WIH Institutional Review Board.
Statistics
Repeated measures analysis was used to estimate the relationship of protein intake in the first week of life with BUN and HCO 3 À . This method allowed for evaluation of multiple measures on the same infant over time as well as adjustment for the correlation of . If the protein-time interaction term was not statistically significant in a given model, it was removed and the model was re-estimated. These estimates allow for calculation of the net daily effect of protein. 16, 17 Analyses were performed using the Proc Mixed procedure in SAS 9.1 (Cary, NC, USA).
Results
For each neonate, all available laboratory data were collected, giving a total of 359 separate BUN and HCO 3 À values for analysis. Both parenteral amino acids and enteral protein were included, and data are reported as actual amount received. None of the infants received enteral protein for the first 3 days and the contribution of enteral protein to total protein received in the first week was small. For example on day of life 7, enteral protein accounted for an average of 4.2% of total protein intake. In this cohort, the mean amount of protein (g/kg/day) administered on day of life 1 was 1.6 (range 0.3 to 2.8), on day of life 4 was 2.9 (range 0.75 to 5.2) and on day of life 7 was 3.4 (range 0.7 to 5.5). In the majority of patients, protein administration was <4.5 g/kg/day. However, on day of life 7 there were three patients who received protein intake between 4.5 and 5.5 g/kg/day and on day of life 4 there were three patients who received protein intake between 4.5 and 5.1 g/kg/day. These higher intakes were due to increased enteral protein intake with inadequate adjustment of intravenous administration. The mean BUN value (mg/dl) on day of life 1 was 20.9 (range 6 to 43) and on day of life 7 was 36.0 (range 8 to 110). The mean HCO 3 À value (mmol/l) on day of life 1 was 21.3 (range 12 to 27) and on day of life 7 was 20.1 (range 10 to 31).
Approximately 17% (n ¼ 24) of neonates in this study received at least one sodium bicarbonate bolus within their first week of life.
The first repeated measures analysis (Table 3) evaluates the effect of protein as a continuous variable on BUN. There was a significant increase in mean BUN of 8.9 mg/dl with each day of life (P<0.0001), which was independent of protein intake. Each gram per kilogram per day of protein administered was associated with an increase in mean BUN of 3.3 mg/dl (P ¼ 0.0021); however, this effect was attenuated over time by 2.1 mg/dl (P<0.0001). The average net daily effect of protein on BUN per gram per kilogram of protein administered is 1.2 mg/dl.
The second repeated measures analysis (Table 4) evaluates the effect of protein as a continuous variable on HCO 3 À . There was an insignificant increase in mean HCO 3 À by 0.03 mmol/l with each day of life (P ¼ 0.84), which was independent of protein intake. Each gram per kilogram per day of protein administered was associated with a decrease in mean HCO 3 À by 0.9 mmol/l (P ¼ 0.0031). A protein-time interaction term was not significant in this model (b ¼ 0.08; P ¼ 0.4180) and was not retained in the final version. The average net daily effect of protein on HCO 3 À per gram per kilogram of protein administered is À0.9 mmol/l.
Discussion
A number of studies implicate suboptimal energy and protein intake as major factors in the development of extrauterine growth restriction in low birth weight infants. 3, 6 Recognizing the high incidence of extrauterine growth restriction among ELBWs, many neonatologists advocate the administration of higher amounts of protein and calories at an earlier time. However, no consensus currently exists in regard to protein administration in ELBWs. There is wide variability in when protein is initiated, the amount at which protein is initiated, rates of increasing protein administration, goal protein administration and duration to attainment of the maximum protein goal. Much of this variation in practice is related to concerns of protein tolerance.
Historically, the predominant concerns with amino-acid administration have been its metabolic effects in premature neonates such as the occurrence of high BUN, metabolic acidosis and hyperammonemia. Studies in fetal lambs suggest that aminoacid intake contributes to growth through protein synthesis as well as generation of energy through oxidation. 18 Amino-acid metabolism occurs in the liver, kidney, small intestines and skeletal muscle. The majority of amino-acid catabolism occurs in the liver and results in the production of glucose, urea and carbon dioxide. Amino-acid catabolism in the small intestine leads to the production of ammonia, which is then excreted by the kidney or enters the urea cycle for detoxification by the liver. Increased amino-acid intake is thought to result in increased urea and ammonia production. 9, 19, 20 However, as noted by Thureen et al.,
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'an elevated urea concentration in the ELBW infant may reflect an acceptable generation of an acceptable metabolic by-product and not protein intolerance.' A number of studies have disputed the association of hyperammonemia and metabolic acidosis with the amount of amino-acid intake in the early neonatal period. 4, 8, 12, 14, 21, 22 Thus, measures of BUN, metabolic acidosis and hyperammonemia are likely a poor gauge for amino-acid intolerance in ELBWs.
There are several retrospective studies evaluating protein administration <4 g/kg/day which have included premature, low birth weight neonates and have found administration to be metabolically safe with the advantage of improving both growth and nitrogen balance. However, these studies were done with relatively small numbers of patients with a maximum amino-acid administration of 2.6 g/kg/day and most did not evaluate patients until after the first day of life. 10 Kotsopoulos et al. performed a prospective observational study of early amino-acid administration during an institutional practice change evaluating 108 very low birth weight (VLBW) neonates <28 weeks gestation providing 1 g/ kg/day immediately after stabilization versus at 12 to 30 h of life. They found no clinically significant associations between protein intake and degree of acidosis or BUN. 23 Ridout et al. retrospectively evaluated 121 neonates with birth weight <1250 g who received exclusive parenteral nutrition in the first 3 days of life providing amino-acid intakes up to 3.7 g/kg/day. They found no association between BUN and protein intake in their study. 9 Radmacher et al. retrospectively reviewed 188 ELBWs in their first 5 days of life over a non-consecutive 7-year time period to assess safety of amino acids administered at 1.2 to 4 g/kg/day. They also found there to be no relationship between BUN and protein intake. 24 There are several randomized controlled trials that have evaluated the effects of protein administration in VLBW infants and which have found early administration of amino acids to be well tolerated. Wilson et al. randomized 125 VLBW infants to an aggressive parenteral and enteral nutritional regimen (goal protein load of 2.5 to 3.5 g/kg/day) versus a controlled conservative nutritional regimen (goal protein load of 2.5 g/kg/day). They found no increased risk of metabolic sequelae in the neonates who received their aggressive nutritional regimen. 15 Thureen et al. studied 28 neonates <1300 g, randomizing patients to a low amino acid (goal protein load 1 g/kg/day) versus a high amino-acid group (goal protein load 3 g/kg/day) at B24 h of life. While no association between BUN and protein load was detected, the high amino-acid group had improved endogenous insulin production and protein accretion rates. 4 Ibrahim et al. evaluated 32 ventilatordependent neonates with birth weight <1250 g randomizing neonates to receive TPN containing 3.5 g/kg/day of protein and 3 g/kg/day of lipid within 1 h of life versus delaying introduction of protein until the second day of life. The late TPN group initiated protein at 2 g/kg/day and lipid at 0.5 g/kg/day with incremental increases to reach a goal protein load of 3.5 g/kg/day and lipid load of 3 g/kg/day. This study resulted in no differences in BUN values between the two groups but improved nitrogen retention in the group received higher amounts of protein and lipid earlier. 12 te Braake et al. randomized 135 VLBW infants to an intervention group which received 2.4 g/kg/day of protein on days 1 to 4 and a control group initiating protein on day of life 2 which increased to 2.4 g/kg/day on days 3 and 4. They found improved nitrogen retention in their intervention group and statistically, but not clinically significant differences in BUN and degree of acidosis. 14 Clark et al. studied 122 neonates with birth weight <1250 g and randomized infants to different approaches of parenteral aminoacid administration. Group 1 started protein administration at 1 g/kg/day with advancements to reach a goal of 2.5 g/kg/day by day of life 4. Group 2 initiated protein administration at
